Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

1994 • 850 citations

T cell defined tumor antigens

1997 • 641 citations

Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.

1994 • 584 citations

Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression.

1995 • 552 citations

Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.

1991 • 402 citations

Expression of MAGE genes in primary and metastatic cutaneous melanoma

1995 • 285 citations

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.

1996 • 259 citations

Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy.

1994 • 247 citations

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene.

1996 • 235 citations

Antibodies to normal human melanocytes in vitiligo.

1983 • 221 citations

The role of tyrosinase in autoimmune vitiligo

1994 • 198 citations

Antiviral immunity

1997 • 69 citations

Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.

1997 • 62 citations

gamma-Interferon plays a key role in T-cell-induced tumor regression.

1993 • 61 citations

Specific Release of Cytokines by Lymphocytes Infiltrating Human Melanomas in Response to Shared Melanoma Antigens

1993 • 59 citations

Peptide‐specific ctl in tumor‐infiltrating lymphocytes from metastatic melanomas expressing mart‐1/melan‐a, gp100 and tyrosinase genes: A study in an unselected group of hla‐a2.1‐positive patients

1995 • 59 citations

Tumor-specific granulocyte/macrophage colony-stimulating factor and interferon ? secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cells

1995 • 51 citations

In vitro induction of tumor-specific immunity. IV. Specific adoptive immunotherapy with cytotoxic T cells induced in vitro to plasmacytoma antigens

1977 • 38 citations

Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription.

1997 • 36 citations

Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.

1998 • 36 citations

Heterogeneity of biologic responses of melanoma-specific CTL.

1997 • 34 citations

Successful Adoptive Cellular Immunotherapy Is Dependent on Induction of a Host Immune Response Triggered by Cytokine (IFN-γ and Granulocyte/Macrophage Colony-Stimulating Factor) Producing Donor Tumor-Infiltrating Lymphocytes

1998 • 29 citations

Lymphokine production by human melanoma tumor-infiltrating lymphocytes

1992 • 18 citations

High proliferative capacity and specific antiautologous melanoma cytotoxicity of a human t-lymphocyte clone derived from tumor-infiltrating lymphocytes

1990 • 5 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...